Monciino, P.; Magagnoli, L.; Fasulo, E.; Frittoli, M.; Leotta, C.; Pham, H.N.; Stucchi, A.; Ciceri, P.; Galassi, A.; Cozzolino, M.
Efficacy and Safety of Etelcalcetide in Hemodialysis Patients with Moderate to Severe Secondary Hyperparathyroidism. Kidney Dial. 2022, 2, 482-494.
https://doi.org/10.3390/kidneydial2030044
AMA Style
Monciino P, Magagnoli L, Fasulo E, Frittoli M, Leotta C, Pham HN, Stucchi A, Ciceri P, Galassi A, Cozzolino M.
Efficacy and Safety of Etelcalcetide in Hemodialysis Patients with Moderate to Severe Secondary Hyperparathyroidism. Kidney and Dialysis. 2022; 2(3):482-494.
https://doi.org/10.3390/kidneydial2030044
Chicago/Turabian Style
Monciino, Paola, Lorenza Magagnoli, Eliana Fasulo, Michela Frittoli, Chiara Leotta, Hoang Nhat Pham, Andrea Stucchi, Paola Ciceri, Andrea Galassi, and Mario Cozzolino.
2022. "Efficacy and Safety of Etelcalcetide in Hemodialysis Patients with Moderate to Severe Secondary Hyperparathyroidism" Kidney and Dialysis 2, no. 3: 482-494.
https://doi.org/10.3390/kidneydial2030044
APA Style
Monciino, P., Magagnoli, L., Fasulo, E., Frittoli, M., Leotta, C., Pham, H. N., Stucchi, A., Ciceri, P., Galassi, A., & Cozzolino, M.
(2022). Efficacy and Safety of Etelcalcetide in Hemodialysis Patients with Moderate to Severe Secondary Hyperparathyroidism. Kidney and Dialysis, 2(3), 482-494.
https://doi.org/10.3390/kidneydial2030044
